Regulation And Legal
Aurobindo Pharma US FDA Inspection Concludes with One Observation
Aurobindo Pharma subsidiary AuroPeptides Ltd completed a US FDA inspection with only one minor observation.
The observation relates to facility and equipment maintenance, not data integrity or GMP com
